Sponsored Video

Please note that clicking on this video will direct you to a third-party website.

Dr Crawford Video

Despite current interventions, chemotherapy‐induced myelosuppression can result in a range of different adverse events—neutropenia, anemia, and thrombocytopenia. Given the challenges health systems are now facing, more healthcare visits can create management challenges and additional burden on patients. Hear what Dr. Jeffrey Crawford (Medical Oncologist) has to say about the ongoing challenges of myelosuppression and hematopoietic stem and progenitor cell (HSPC) damage during chemotherapy.

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State
  • Please enter your mailing address.

    Address Line 2
    Zip Code